The CosmosID metabolomics service comprises a combination of LC-MS and GC-MS, deployed to test samples, and includes CosmosID metabolomics profiling in an "untargeted" approach enabling broad coverage and highly accurate detection of +100,000 metabolites. more...

In this article, Dr. Ursula Leuthold, sustainability coordinator for INTEGRA Biosciences explores how labs can mimimise their environmental impact and invites you to download a free poster full of valuable insights. more...

Biose and SBT will create a new industrial standard for the enumeration of microorganisms. The implementation of rapid viable cell counts in both process and release testing aims to shorten the journey from clinical trials to market authorization for Biose’s innovative live biotherapeutic companies. more...